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associated with T2D comorbidity in SMI. The analysis considered 3816 individuals with an SMI living in 
the Illawarra and Shoalhaven regions of NSW, Australia, between 2010 and 2017. Multilevel logistic 
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significant geographic variation in the distribution of SMI -T2D comorbidity in our sample (Median Odds 
Ratio = 1.35) Neighbourhood socioeconomic disadvantage accounted for approximately 17.3% of this 
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Abstract: This study examined the association between neighbourhood socioeconomic disadvantage
and serious mental illness (SMI)–type 2 diabetes (T2D) comorbidity in an Australian population using
routinely collected clinical data. We hypothesised that neighbourhood socioeconomic disadvantage
is positively associated with T2D comorbidity in SMI. The analysis considered 3816 individuals with
an SMI living in the Illawarra and Shoalhaven regions of NSW, Australia, between 2010 and 2017.
Multilevel logistic regression models accounting for suburb (neighbourhood) level clustering were
used to assess the association between neighbourhood disadvantage and SMI -T2D comorbidity.
Models were adjusted for age, sex, and country of birth. Compared with the most advantaged
neighbourhoods, residents in the most disadvantaged neighbourhoods had 3.2 times greater odds
of having SMI–T2D comorbidity even after controlling for confounding factors (OR 3.20, 95% CI
1.42–7.20). The analysis also revealed significant geographic variation in the distribution of SMI -T2D
comorbidity in our sample (Median Odds Ratio = 1.35) Neighbourhood socioeconomic disadvantage
accounted for approximately 17.3% of this geographic variation. These findings indicate a potentially
important role for geographically targeted initiatives designed to enhance prevention and management
of SMI–T2D comorbidity in disadvantaged communities.
Keywords: neighbourhood disadvantage; serious mental illness; type 2 diabetes; comorbidity
1. Introduction
Serious mental illness (SMI) is a term used to refer to severe and persistent forms of mental
disorders such as schizophrenia, bipolar disorder or major depression [1]. Individuals with SMI have 2
to 4 times increased risk of developing type 2 diabetes (T2D) compared with the general population
which translates into a reduction of 15–20 years in their life expectancies [2–4]. A comorbid T2D
diagnosis is also associated with other adverse consequences such as increased hospitalisations, greater
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number of emergency department visits, non-adherence to treatments, higher healthcare utilisation
costs, higher risk of cognitive deficit, poor clinical outcomes and decreased quality of life for the
mentally ill. [2,5–11].
People with SMI are more likely to live in disadvantaged neighbourhoods [12,13] and the
environment in these neighbourhoods may compound the experiences of psychosocial stress or
promote engagement in adverse health behaviours (e.g. unhealthy eating and physical inactivity)
and weight gain, all of which contribute to T2D risk [12,14,15]. A number of studies have found that
the prevalence of SMI and T2D are both separately higher in more socioeconomically disadvantaged
neighbourhoods [13,16–19]. However, research to date has not adequately examined the association
between area-level disadvantage and SMI–T2D comorbidity. A recent systematic review [20] examining
this relationship identified only a single study demonstrating a tentative association between the
neighbourhood level disadvantage and T2D comorbidity in mental illness [21]. The aforementioned
study, however, focused entirely on major depression and did not consider other forms of SMI
such as schizophrenia or bipolar disorder. Hence additional research on the association between
neighbourhood disadvantage and SMI–T2D comorbidity is warranted, given the paucity of evidence
available and the plausibility of an association. We have recently reported significant geographic
variations in the distribution of SMI–T2D comorbidity suggesting the need to explore the role of
neighbourhood level disadvantage in explaining this variation [22].
Establishing strong evidence of the relationship between neighbourhood disadvantage and SMI
–T2D comorbidity is an important step in advancing our understanding of the T2D comorbidity in SMI
and the possible associations with neighbourhood environments might have with this comorbidity.
Moreover, population-based prevention strategies that shift the risk distribution of entire population
in a favourable direction are considered more effective and sustainable than the individual-based
approaches in reducing the disease burden [23]. Understanding these associations may also be useful
for health policymakers to develop integrated interventions and to provide greater diversity of care
needed to optimally manage the complex needs associated with comorbidity.
The aim of this study was to investigate the association between neighbourhood socioeconomic
disadvantage and SMI–T2D comorbidity in an Australian population using routinely collected
clinical data. We hypothesised that greater socioeconomic disadvantage would be associated with
increased T2D comorbidity in SMI. A further objective was to determine how much variance of SMI-T2D
comorbidity between neighbourhoods was attributable to neighbourhood socioeconomic disadvantage.
2. Materials and Methods
2.1. Study Design and Sample
We used a cross-sectional, multilevel study design to examine the association between
neighbourhood socioeconomic disadvantage and SMI-T2D comorbidity. The study area comprised the
Illawarra and Shoalhaven regions of NSW, Australia, which had an estimated resident population of
368,604 people at the time of the 2011 Australian Census of Population and Housing [24]. The region
has a mix of rural and urban influences and is comprised of the local government areas of Kiama,
Shellharbour, Shoalhaven, and Wollongong. The socio-economic profile of the study area as described
by region’s socio-economic index scores are comparable to that of NSW and Australian average [25,26].
The data analysed in this study covered the period 01 January 2010 to 31 December 2017 and were
retrieved from Illawarra Health Information Platform (IHIP). The IHIP is a research partnership
established between Illawarra Shoalhaven Local Health District (ISLHD) and University of Wollongong
for the purpose of providing ISLHD health service data to clinicians and researchers. The analysis was
undertaken at the state suburb level (SSCs), which was the smallest geographic unit at which the health
service data were available. State suburbs are the Australian Bureau of Statistics (ABS) approximation
of suburbs gazetted by the Geographical Names Board of NSW [27]. The Illawarra-Shoalhaven region
comprised of 167 suburbs with an average land area of 36.56 km2 and 2207 residents each in 2011 [24].
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This study was approved by the University of Wollongong and Illawarra Shoalhaven Local Health
District Human Research Ethics Committee (protocol number 2017/428).
2.2. Measures
Data extraction was carried out using International Classification of Diseases (ICD) version
10 codes and was restricted to adults 18 years and over. We defined SMI as having a primary or
secondary diagnosis of schizophrenia (F20), other non-affective psychosis (F22–F29), bipolar disorder
(F30, F31), major depression (F32, F33) or other affective disorders (F34, F39) in the inpatient records
of ISLHD. Diabetes comorbidity, the outcome of interest, was defined as having a T2D diagnosis
(E11) in people with SMI and was extracted as either present or absent along with each of the SMI
records. The analytical sample was formed by excluding individuals residing outside the Illawarra and
Shoalhaven regions (n = 50) and individuals with no suburb (n = 283) or country of birth information
(n = 8). The final SMI sample consisted of 3816 individuals of whom 463 (12.09 %) had T2D comorbidity.
Neighbourhood socioeconomic disadvantage was operationalised for suburbs using the Index of
Relative socioeconomic disadvantage (IRSD) from the 2011 Socioeconomic Indexes for Area Census
product [26]. An IRSD score reflects the aggregate level of socioeconomic disadvantage measured
on the basis of 17 variables including education, income, occupation, unemployment, housing type,
overcrowding, and English proficiency. For this study, IRSD scores for Illawarra and Shoalhaven suburbs
were divided into quintiles of neighbourhood disadvantage with Quintile one (Q1) denoting the 20%
most disadvantaged suburbs in Illawarra-Shoalhaven and Quintile five (Q5) the least disadvantaged
20%. Global Moran’s I revealed a significant spatial dependence for neighbourhood socioeconomic
disadvantage quintiles (Moran’s I = 0.443673, p < 0.0001) indicating that suburbs with similar relative
neighbourhood disadvantage are clustered geographically [28]. Quintiles were then assigned to
individuals based on their suburb of residence at their most recent admission before 31 December 2017.
Individual-level variables included in the analysis were sex, age at most recent admission and the
country of birth. Age was categorised into three age groups (18–44, 45–65, 65+) and sex were grouped
as male or female. Country of birth data was aggregated based on the Standard Australian Classification
of Countries produced by the Australian Bureau of Statistics [29].
2.3. Statistical Analysis
Multilevel logistic regression models accounting for suburb level clustering were used to assess
the association between neighbourhood disadvantage and SMI–T2D comorbidity. The data structure
consisted of two levels with individuals (level 1) nested within suburbs (level 2). A series of models
were fit as follows: model 1 included only suburb level random effect, model 2 added individual
level factors (age, gender, country of birth) to model 1, and model 3 added neighbourhood level IRSD
quintiles to model 2. Interactions between individual variables and neighbourhood disadvantage were
also considered in modelling to investigate any cross-level effect modification of the association by
individual-level factors. Models were estimated using the maximum likelihood method with Laplace
approximation [30]. Intra class correlation (ICC) and Median Odds ratios (MOR) were calculated
for each model to assess how much of the variance in comorbidity could potentially be attributed
to neighbourhoods [31,32]. ICC informs us regarding the variance between areas [31]. The MOR
is interpreted as the increased risk in comorbidity when an individual moves to a suburb of higher
disadvantage [33]. MOR closer to 1 implies little variation between areas whereas larger MOR values
indicate considerable variation between areas [33]. We also reported proportional change in variance
(PCV) to show how much of the residual variance was explained by the additional explanatory variables
in each of the models. ICC, MOR, and PCV were derived from model outputs following the methods
specified by Merlo et al and Austin et al [31,32]. Likelihood ratio tests were used to determine the
goodness of fit of the models. All statistical analysis was completed using R version 3.5 [34]. Statistical
significance in this analysis was set at p < 0.05.
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3. Results
The descriptive characteristics of the study population are given in Table 1. SMI-T2D comorbidity
was present in 13.3% of females and 11.1% of males with an SMI diagnosis. The age group with highest
proportion of comorbidity was 65+ (27.73%). With regards to country of birth, a higher percentage of
T2D comorbidity was observed for SMI individuals born in Middle East and North Africa (23.1%),
Eastern and Central Europe (23.2%) and Western Europe (21.2%). The SMI-T2D comorbidity prevalence
in the most disadvantaged IRSD quintile (Q1) was 13.1% (n = 229) and that in the least disadvantaged
quintile (Q5) was 5.1% (n = 7).
Table 2 presents the results of the multilevel logistic regression analysis. Model 1 provides
the estimate of between area variation in SMI–T2D comorbidity without any explanatory variables.
The MOR for model 1 was 1.35, indicating some level of geographic variation in the distribution of
SMI-T2D comorbidity in our sample. Moreover, the ICC for model 1 was 0.029, showing that 2.9% of
the variance in comorbidity was attributable to between neighbourhood differences. The addition of
individual level variables in model 2 accounted for 25.5% of between area variance and addition of
IRSD in model 3 accounted for an additional 17.3% and reduced the MOR to 1.25. After inclusion of
individual and neighbourhood variables, the ICC decreased from 2.9% to 1.7%.
Table 1. Characteristics of study population Variables.
Variables Individuals withSMI n = 3816
Individuals with
SMI–T2D Comorbidity
n = 463
% of Individuals with
SMI who Also Have
Comorbidity (95% Cl)
Individual variables
Gender
Female 1848 (48%) 245 (53%) 13.3 (11.8–14.9)
Male 1968 (52%) 218 (47%) 11.1 (9.7–12.5)
Age, years (Mean (SD))
Age, years 43.6 (18.5) 58.8 (15.7)
18–44 1961 (51%) 92 (20%) 4.7 (03.8–05.7)
45–65 1213 (32%) 193 (42%) 15.9 (13.9–18.0)
65+ 642 (17%) 178 (38%) 27.7 (24.3–31.2)
Country of birth
Australia 3104 (81%) 339 (73%) 10.9 (9.9–12.1)
Oceania excluding Australia 74 (2%) 12 (3%) 16.2 (9.5–26.2)
UK & Ireland 212 (6%) 35 (8%) 16.5 (12.1–22.1)
Western Europe 137 (4%) 29 (6%) 21.2 (15.2–28.8)
Eastern and Central Europe 125 (3%) 29 (6%) 23.2 (16.7–31.3)
North East Asia 17 (0%) 0 (0%) 0.0 (0–18.4)
South East Asia 51 (1%) 6 (1%) 11.8 (5.5–23.4)
Central and South Asia 16 (0%) 3 (1%) 18.8 (6.6–43.0)
Middle East and North Africa 39 (1%) 9 (2%) 23.1 (12.7–38.3)
Sub-Saharan Africa 20 (1%) 0 (0%) 0.0 (0–16.1)
Americas 21 (1%) 1 (0%) 4.8 (0.9–22.7)
Neighbourhood level variables
IRSD as quintiles
Q1 (Highest) 1752 (46 %) 229 (49%) 13.1 (11.6–14.7)
Q2 943 (25 %) 120 (26%) 12.7 (10.7–14.9)
Q3 620 (16 %) 75 (16%) 12.1 (9.8–14.9)
Q4 362 (10 %) 34 (7%) 9.4 (6.8–12.8)
Q5 (Lowest) 139 (4 %) 7 (2%) 5.1 (2.5–10.0)
IRSD = Index of Relative Socioeconomic Disadvantage.
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Table 2. The association between neighbourhood socioeconomic disadvantage and serious mental
illness (SMI)–type 2 diabetes (T2D) comorbidity using multilevel analysis (Illawarra – Shoalhaven,
2010–2017).
Variable
Model 1 Model 2 Model 3
OR (95% Cl) OR (95% Cl) OR (95% Cl)
Individual variables
Gender p = 0.658 p = 0.687
Female 1.00 1.00
Male 0.95 (0.78–1.17) 0.96 (0.78–1.17)
Age p < 0.05 p < 0.05
18–44 1.00
45–65 3.79 (2.91–4.93) 3.78 (2.90–4.92)
65+ 7.68 (5.77–10.23) 7.82 (5.87–10.42)
Country of birth p = 0.137 p = 0.149
Australia 1.00 1.00
Oceania excluding Australia 1.57 (0.81–3.03) 1.53 (0.79–2.97)
UK & Ireland 0.84 (0.57–1.26) 0.88 (0.59–1.31)
Western Europe 0.99 (0.63–1.54) 0.97 (0.62–1.52)
Eastern and Central Europe 1.30 (0.82–2.05) 1.30 (0.82–2.06)
South East Asia 1.30 (0.53–3.19) 1.30 (0.52–3.19)
Central and South Asia 2.03 (0.53–7.82) 2.13 (0.56–8.10)
Middle East and North Africa 1.84 (0.83–4.09) 1.87 (0.84–4.16)
Americas 0.42 (0.06–3.25) 0.41 (0.05–3.15)
Neighbourhood Variable
IRSD quintiles p <0.05
Q5 (Least disadvantaged) 1.00
Q4 1.87 (0.77–4.53)
Q3 2.67 (1.14–6.15)
Q2 2.92 (1.28–6.67)
Q1 (Most disadvantaged) 3.20 (1.42–7.20)
Variance of random effects
T2 0.098 0.073 0.056
PCV Ref 25.5% 42.9%
ICC 0.029 0.0217 0.017
MOR 1.347 1.293 1.252
OR: Odds Ratio, 95% Cl: 95% confidence interval, T2: Area level variance, PCV: Proportional change in Variance,
ICC: Intra Class Correlation, MOR: Median Odds Ratio, Model 1: Null model with suburb level random effect,
Model2: Model 1 + individual-level factors, Model 3: Model 2+ neighbourhood level IRSD quintiles.
Results for individual-level variables in Model 2 indicate that age was significantly associated
with SMI-T2D comorbidity. Older individuals with SMI have significantly higher odds of having T2D
comorbidity compared with younger individuals. Model 3 showed a significant association between
higher levels of neighbourhood disadvantage and diabetes comorbidity in SMI after controlling for age,
gender and country of birth. Living in a neighbourhood with the highest socioeconomic disadvantage
was associated with 3 times increased odds of having SMI-T2D comorbidity compared with the least
disadvantage neighbourhood (OR 3.20, 95% CI 1.42–7.20 for Q1 vs Q5). Including two-way interaction
terms in Model 3 indicated no evidence of effect modification of the association between SMI–T2D
comorbidity and IRSD by age (χ2LRT = 14.16, DF = 8, p = 0.077), gender (χ2LRT = 1.45, DF = 4, p = 0.835)
or country of birth (χ2LRT = 30.68, DF = 38, p = 0.794).
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4. Discussion
We found an independent positive association between neighbourhood disadvantage and SMI–T2D
comorbidity after controlling for individual age, gender and country of birth. Neighbourhood
socioeconomic disadvantage accounted for 17.3% of the between neighbourhood variation in SMI–T2D
comorbidity. Among the individual-level factors, age was independently associated with SMI–T2D
comorbidity. Individual factors accounted for 25.5% of the between neighbourhood variation. Neither
gender nor country of birth were associated with SMI-T2D comorbidity. Lower neighbourhood
variance in SMI–T2D comorbidity (ICC = 0.029) reported in our study does not preclude important
neighbourhood level effects [35]. Misspecification of neighbourhoods, smaller group sizes and even
omission of a relevant level 1 variable can all cause under estimation of neighbourhood variance [36].
Low Intra class correlation (ICC) can coexist with important neighbourhood level fixed effects
and several of these examples are available in public health where risk factors explain very little
neighbourhood variance but are important predictors of health outcomes [36]. Additionally, Geoffrey
Rose had pointed out that even small neighbourhood effects, when aggregated at population scales,
can have a massive impact [23]. Ours appears to be one of the first studies to explore the association
between area level disadvantage and SMI–T2D comorbidity. The only other study addressing this
research question investigated major depression only and reported a positive but non-significant
association between area level disadvantage and SMI–T2D comorbidity [21]. Our findings are,
however, consistent with prior studies, which show significant neighbourhood level socioeconomic
inequalities in the distribution of SMI [13,17,37] and T2D [18,19,38,39] as independent conditions.
In their systematic review, Mair et al identified 45 studies, of which 37 reported significant associations
between neighbourhood characteristics and depression [40]. Similarly, the significant associations
between neighbourhood environments and T2D risk were revealed in another systematic review by
Dendup et al. [41]. The findings of a positive significant association between SMI–T2D comorbidity
and age and a non-significant association between SMI–T2D comorbidity and gender are consistent
with previous reports in the literature [3,42,43].
The results of this study have policy implications for planning interventions and resourcing public
health services. Our results indicate that efforts to reduce diabetic comorbidity in serious mental
illness might benefit by focussing on individuals with SMI living in high deprivation neighbourhoods.
These results also have future research implications. Understanding why neighbourhood level
disadvantage is associated with comorbidity is an important next step in addressing these inequities
and in developing sustainable interventions and long-term solutions. There are several plausible
explanations for increased SMI–T2D comorbidity in more disadvantaged neighbourhoods, over and
above individual level factors. Neighbourhood level features, such as green spaces, access to health
care services, availability of fast food restaurants and area level crime may be differentially present in
advantaged and disadvantaged neighbourhoods [44]. These may in turn act as a stimulus for chronic
stress or adverse health behaviours such as unhealthy eating, lack of physical activity and obesity,
which have been shown to be associated with increased T2D risk [12,14,15]. Further exploration of the
mediating or confounding roles played by these contextual variables may improve our understanding
of SMI–T2D comorbidity and the casual pathways linking them with the neighbourhood environments.
There are some limitations to our study. First, the cross-sectional study design does not allow us
to draw cause-effect conclusions. Second, we used data sourced only from inpatient mental health
records and did not consider outpatient and private practice records. However, the Australian National
Surveys of Psychosis indicates that 45.6–62.9% of people with SMI reported ≥1 hospital admission
for any reason in the previous 12 months [45], which should have provided a reasonable coverage
given our eight-year data collection period. In addition, we acknowledge the potential for temporal
misalignment as 2011 relative disadvantage index scores were used in this analysis. Nonetheless a
weighted Kappa analysis between 2011 and 2016 disadvantage quintiles revealed a good agreement
between the two (k = 0.796) indicating that the deprivation scores have remained relatively similar
during these periods. Individual socioeconomic status, ethnicity, age at diagnosis and number of
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hospital admissions, were not included in this analysis due to the lack of data availability. This may
have resulted in the overestimation of neighbourhood level effects. Finally, we also acknowledge the
potential for reverse causation as SMI and T2D share a bidirectional association.
5. Conclusions
Our results indicate that the people with SMI living in the most disadvantaged neighbourhoods
are more likely than their counterparts in the least disadvantaged neighbourhoods to report SMI-T2D
comorbidity. These findings highlight the need to consider public health prevention strategies at
both individual and neighbourhood level in order to reduce the public health burden imposed by
comorbidity. The current study makes a significant contribution to the scant research literature available
in this area of public health. Future research is needed to extend these findings and to consider how
various neighbourhood contextual features may mediate the effect of neighbourhood socioeconomic
disadvantage on SMI–T2D comorbidity.
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